Rekah Pharmaceutical Industry Ltd. (REKA.TA)
ILA 1176.0
(-1.26%)
ILA 1176.0
(-1.26%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 178.9 Million ILS | 15.89% |
| 2022 | 154.37 Million ILS | -6.9% |
| 2021 | 165.82 Million ILS | -0.31% |
| 2020 | 166.34 Million ILS | 15.3% |
| 2019 | 144.26 Million ILS | 71.15% |
| 2018 | 84.29 Million ILS | 5.33% |
| 2017 | 80.02 Million ILS | -15.83% |
| 2016 | 95.07 Million ILS | 4.37% |
| 2015 | 91.09 Million ILS | -42.16% |
| 2014 | 157.48 Million ILS | 11.13% |
| 2013 | 141.7 Million ILS | 0.0% |
| 2012 | - ILS | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 173.39 Million ILS | -3.08% |
| 2024 Q2 | 132.27 Million ILS | -23.71% |
| 2023 Q2 | 167.06 Million ILS | 4.35% |
| 2023 FY | 178.9 Million ILS | 15.89% |
| 2023 Q1 | 160.1 Million ILS | 3.71% |
| 2023 Q4 | 178.9 Million ILS | 5.76% |
| 2023 Q3 | 169.16 Million ILS | 1.25% |
| 2022 FY | 154.37 Million ILS | -6.9% |
| 2022 Q2 | 166.34 Million ILS | 6.0% |
| 2022 Q3 | 158.57 Million ILS | -4.67% |
| 2022 Q4 | 154.37 Million ILS | -2.65% |
| 2022 Q1 | 156.93 Million ILS | -5.36% |
| 2021 FY | 165.82 Million ILS | -0.31% |
| 2021 Q4 | 165.82 Million ILS | -5.56% |
| 2021 Q3 | 175.58 Million ILS | 7.6% |
| 2021 Q1 | 156.41 Million ILS | -5.97% |
| 2021 Q2 | 163.17 Million ILS | 4.32% |
| 2020 Q3 | 168.32 Million ILS | 12.08% |
| 2020 Q1 | 163.82 Million ILS | 13.55% |
| 2020 Q2 | 150.18 Million ILS | -8.32% |
| 2020 Q4 | 166.34 Million ILS | -1.18% |
| 2020 FY | 166.34 Million ILS | 15.3% |
| 2019 Q3 | 121.48 Million ILS | 17.05% |
| 2019 FY | 144.26 Million ILS | 71.15% |
| 2019 Q2 | 103.79 Million ILS | -17.5% |
| 2019 Q1 | 125.8 Million ILS | 49.25% |
| 2019 Q4 | 144.26 Million ILS | 18.75% |
| 2018 Q1 | 102.15 Million ILS | 27.65% |
| 2018 Q4 | 84.29 Million ILS | -3.7% |
| 2018 Q3 | 87.53 Million ILS | 1.68% |
| 2018 Q2 | 86.08 Million ILS | -15.73% |
| 2018 FY | 84.29 Million ILS | 5.33% |
| 2017 Q3 | 81.19 Million ILS | -0.08% |
| 2017 FY | 80.02 Million ILS | -15.83% |
| 2017 Q2 | 81.26 Million ILS | -13.69% |
| 2017 Q1 | 94.15 Million ILS | -0.97% |
| 2017 Q4 | 80.02 Million ILS | -1.44% |
| 2016 Q1 | 110.3 Million ILS | 21.09% |
| 2016 FY | 95.07 Million ILS | 4.37% |
| 2016 Q4 | 95.07 Million ILS | -5.9% |
| 2016 Q3 | 101.04 Million ILS | 4.21% |
| 2016 Q2 | 96.95 Million ILS | -12.1% |
| 2015 FY | 91.09 Million ILS | -42.16% |
| 2015 Q4 | 91.09 Million ILS | -3.73% |
| 2015 Q3 | 94.62 Million ILS | 1.24% |
| 2015 Q2 | 93.47 Million ILS | -36.77% |
| 2015 Q1 | 147.81 Million ILS | -6.14% |
| 2014 Q1 | 164.49 Million ILS | 16.08% |
| 2014 FY | 157.48 Million ILS | 11.13% |
| 2014 Q4 | 157.48 Million ILS | 5.58% |
| 2014 Q3 | 149.16 Million ILS | -2.64% |
| 2014 Q2 | 153.21 Million ILS | -6.86% |
| 2013 Q1 | 137.47 Million ILS | 0.0% |
| 2013 Q3 | 139.8 Million ILS | 0.94% |
| 2013 FY | 141.7 Million ILS | 0.0% |
| 2013 Q2 | 138.49 Million ILS | 0.74% |
| 2013 Q4 | 141.7 Million ILS | 1.36% |
| 2012 FY | - ILS | 0.0% |
| 2012 Q4 | - ILS | 0.0% |
| 2012 Q3 | - ILS | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Cannabotech LTD | 1.55 Million ILA | -11441.935% |